China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China

SHENZHEN, CHINA – China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 30 July 2024, the New Drug …

China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China Read More